Ecg Laboratory ECG Laboratory

Richmond Pharmacology’s Core ECG Laboratory was established in 2004 to provide centralized electrocardiography data analysis for both Richmond’s in house clinical trials, in addition to analysis for multicenter clinical trials.

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of experienced cardiologist’s headed by Professor John Camm, a key opinion leader in Thorough QT Trials.

Richmond Pharmacology’s Core ECG Laboratory has worked with numerous clinical units worldwide and participated in 200 clinical trials sponsored by pharmaceutical companies.

Analysis services include rest and exercise ECG analysis, detailed QT analysis, entry criteria validation, and cardiac event classification and holter provision, analysis and review. Drug development range of services cover phase I-IV ECG safety studies for cardiovascular and non-cardiovascular compounds. Rest, exercise and QT digitized ECG analysis are performed using Richmond’s bespoke and integrated MUSE setup.

Additional Core ECG Lab services include:

Case studies

The thorough approach to QTc studies ("Your perfect partner for conducting definitive thorough QT studies, all under one roof")

Timelines, Tight Timelines and Even Tighter Timelines in a Phase I Environment (We know we can help your business. We always rise to the challenge)